text.skipToContent text.skipToNavigation

News from the impurity front

Recent developments at ICH, EMA and FDA The requirements when and how to test on impurities are in constant development. Not only the above mentioned regulatory bodies are involved, also the pharmacopoeias – and there USP in particular with their push for new chapters on heavy metal testing – develop and revise their impurity related chapters in an ongoing manner. View our recorded lecture from CPhI 2012 in Madrid: It will give an overview about the regulatory structure and the players in this field, and what the pharmaceutical industry can do to meet these requirements in the best approach possible. Speaker is Dr Christian Zeine, Global Product Manager Pharmaceuticals, LGC Standards. Do you want to get the presentation slides? Simply email us at askus@lgcpharma.com.

print icon Print view


Refine your


Online Ordering made easy


Sign up to our email newsletter



Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.